Conditions: Glaucoma
Keywords: Primary Open-Angle Glaucoma Ocular Hypertension Pigment Dispersion Glaucoma IOP
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 50
Healthy volunteers: no

Brief summary:
The purpose of this study was to assess the safety and intraocular pressure (IOP)-lowering efficacy of changing to DuoTrav® from prior timolol 0.5% monotherapy in participants with open-angle glaucoma or ocular hypertension.

Detailed description:

Arms:
arm 1: Travoprost 0.004%/timolol maleate 0.5% fixed combination, one drop to the study eye nightly for up to 6 weeks

Interventions: intervention 1: Travoprost 0.004%/timolol maleate 0.5% fixed combination
Intervention descriptions: intervention 1: None

Protocol document: